Androgenetic Alopecia
A common hereditary condition that leads to gradual thinning of hair, often seen as receding hairline or crown thinning in men and overall density reduction in women.
Telogen Effluvium is a temporary hair loss condition characterised by sudden, excessive shedding and diffuse thinning across the scalp. At IHT Clinic, specialists assess the cause and suggest appropriate treatment based on your hair condition.
Telogen effluvium is a common hair loss condition characterised by sudden and excessive hair shedding across the scalp. It happens when more hair follicles prematurely enter the telogen (resting) phase of the hair growth cycle.
Under normal conditions, only a small percentage of hair follicles are in the resting phase, while most continue active growth. However, certain physical or emotional stressors can disrupt this balance, causing more hairs to enter the shedding phase simultaneously.
As a result, people may notice increased hair fall during washing, combing, or brushing, along with a gradual decrease in overall hair volume. In many cases, telogen effluvium is temporary, and hair growth may eventually return to normal once the hair cycle stabilises.
Understanding how telogen effluvium affects the hair growth cycle helps dermatologists assess the condition and recommend appropriate management strategies based on the severity of hair shedding.
Telogen effluvium is a condition characterised by excessive hair shedding caused by a temporary disruption in the normal hair growth cycle. As a result, individuals may observe a notable decrease in hair volume and an increase in hair fall over a short timeframe.
Unlike some hair loss conditions that permanently damage hair follicles, telogen effluvium typically does not destroy them, so hair can grow back once the underlying issue improves.
Because excessive hair shedding can sometimes resemble other hair loss disorders, proper evaluation by experienced dermatologists is important. After assessing the scalp condition and the severity of shedding, doctors may recommend appropriate hair-loss treatments or supportive therapies to help restore the hair growth cycle and improve overall scalp health.
Telogen effluvium usually starts with a sudden increase in hair shedding rather than visible bald patches. Since the hair follicles stay active, the condition typically shows as overall thinning of hair density across the scalp. Common signs people notice include:
These symptoms can sometimes be mistaken for other hair loss conditions, which is why recognising the shedding pattern is important when determining the underlying cause of hair fall.
Telogen effluvium typically causes widespread hair shedding on the scalp, but the visible pattern of thinning may differ slightly between men and women. Recognising these patterns helps dermatologists differentiate telogen effluvium from other hair loss conditions.
In Men
Men experiencing telogen effluvium may notice:
In Women
Women with telogen effluvium often report:
Dermatologists assess these patterns along with the clinical history to determine whether the shedding is due to telogen effluvium or another hair-loss condition.
Telogen effluvium is generally considered a temporary, reversible form of hair shedding. In many cases, once the underlying imbalance affecting the hair growth cycle stabilises, hair follicles slowly return to their normal growth pattern and hair density begins to recover. Since telogen effluvium can sometimes be mistaken for other causes of hair loss, it is important to properly identify the condition before starting any treatment.
The condition is often reversible in many individuals and can respond well to appropriate hair loss treatments when needed. However, telogen effluvium can sometimes feel persistent if the triggering factor persists longer or if there are repeated cycles of hair shedding. In such cases, medical evaluation can help identify the underlying cause and guide suitable treatment.
Since telogen effluvium can occur at various stages of hair shedding, prompt evaluation by a doctor can help assess how the condition is advancing and whether any intervention is needed.
You may consider consulting a specialist if you notice:
At India Hair Transplant (IHT), doctors review the pattern and duration of hair shedding to determine whether it is telogen effluvium or another underlying condition, and guide patients on the most appropriate management approach.
Apart from alopecia areata, several other types of hair loss can affect both men and women. Each condition develops due to different underlying causes such as genetics, hormonal changes, stress, medical conditions, or lifestyle factors. Understanding these types helps in identifying the right treatment approach.
Commonly observed hair loss types include:
A common hereditary condition that leads to gradual thinning of hair, often seen as receding hairline or crown thinning in men and overall density reduction in women.
A temporary form of hair loss where excessive shedding occurs due to stress, illness, nutritional deficiency, or hormonal imbalance.
Rapid hair loss that occurs during the growth phase, often associated with medical treatments such as chemotherapy or exposure to certain medications.
Hair loss caused by constant pulling or tension on the hair roots, commonly seen with tight hairstyles, extensions, or repetitive styling practices.
A less common type where inflammation damages hair follicles permanently, leading to irreversible hair loss if not treated early.
Since telogen effluvium usually results from a temporary disturbance in the hair growth cycle, treatment focuses on stabilising the cycle and supporting healthy hair regrowth. The choice of treatment may vary depending on the severity of hair shedding, underlying triggers, and individual scalp condition.
At India Hair Transplant (IHT), doctors assess the pattern of shedding, medical history, and stage of hair thinning before suggesting appropriate hair loss treatments. Some commonly recommended options include:
These treatments aim to support follicle function, enhance scalp health, and decrease ongoing hair shedding in appropriate candidates.